BioNTech SE (BNTX) Raw Materials (2018 - 2021)

BioNTech SE has disclosed Raw Materials across 4 years of filings, most recently posting $284.0 million for Q4 2021.

• Raw Materials for Q4 2021 came in at $284.0 million, up 437.78% year-over-year; the trailing twelve-month figure through Dec 2021 was $284.0 million (up 437.78% YoY), and the FY2021 annual result was $284.0 million, up 437.78% from the prior year.
• Raw Materials came in at $284.0 million for Q4 2021 at BioNTech SE, up from $52.8 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $284.0 million in Q4 2021 to a low of $5.1 million in Q4 2018.
• The 4-year median for Raw Materials is $30.9 million (2020), against an average of $87.8 million.
• Across the five-year window, Raw Materials surged 77.72% in 2019 and surged 481.86% in 2020, its largest moves.
• BioNTech SE's Raw Materials stood at $5.1 million in 2018, then soared by 77.72% to $9.1 million in 2019, then soared by 481.86% to $52.8 million in 2020, then jumped by 437.78% to $284.0 million in 2021.
• The last three Raw Materials figures came in at $284.0 million (Q4 2021), $52.8 million (Q4 2020), and $9.1 million (Q4 2019), per Business Quant data.